Active

LINAFARM

Switched

BE0847606190

Rechtspersoon Private limited company 1 establishment

Bruggestraat 227, 8730 Beernem

Active for

14 year, 1 month

Financials

Financial year 2025

Gross margin

€ -3,042

▲ 38% vs 2024

Profit

Growing

€ 36,963

▲ 825% vs 2024

Debts

Low

€ 48,264

▼ 90% vs 2024

LINAFARM from Beernem, company number BE0847606190, closed financial year 2025 with a result of € 36,963 after tax. For that financial year LINAFARM recorded a gross margin of € -3,042 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € -5,100 to € 36,963. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 3, 2025.

What happened at LINAFARM?

What happened at LINAFARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 36,963. filed late Source: NBB ↗
  • New establishment in Beernem. KBO
  • Start of the company according to the CBE. KBO

In short

From € 1,897 profit in 2022 to € 36,963 profit in 2025.

Paid € 1,262 in corporate taxes since 2022.

Best year ever: 2025, with € 36,963 profit.

A new publication or filing at LINAFARM? We notify you, reason included.

Follow LINAFARM

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Lieven Verschuere

Behind LINAFARM is Lieven Verschuere. Lieven Verschuere is also behind Apotheek Van Overschelde and MEDIFARM.

See the full network in the app

Directors

According to the 2025 annual accounts

Lieven Verschuere

Director

Also active at: Apotheek Van Overschelde, MEDIFARM

Establishments

Establishment units

Physical locations of this company

Registered office

Bruggestraat 227

8730 Beernem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

Details

Company number
0847.606.190
VAT number
BE 0847.606.190
Registered office
Bruggestraat 227, 8730 Beernem
Names & denominations
LINAFARM
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
24 July 2012
Peppol
Not registered

Frequently asked questions

What is the enterprise number of LINAFARM?
The enterprise number of LINAFARM is BE0847606190.
What is the address of LINAFARM?
The registered office of LINAFARM is located at Bruggestraat 227, 8730 Beernem.
When was LINAFARM founded?
LINAFARM was founded on 24 July 2012.
Does LINAFARM have a website?
No website is currently known for LINAFARM.
How much profit did LINAFARM make in 2025?
LINAFARM posted a profit after taxes of € 36,963 in financial year 2025.
What is the revenue of LINAFARM?
As a small company, LINAFARM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -3,042.
Where can I find the annual accounts of LINAFARM?
LINAFARM files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of LINAFARM?
According to the 2025 annual accounts, the directors of LINAFARM are: Lieven Verschuere.
Who owns LINAFARM?
Behind LINAFARM is Lieven Verschuere. Lieven Verschuere is also behind Apotheek Van Overschelde and MEDIFARM.